Bydureon (AstraZeneca) 2017-2018 U.S. Promotional Audit Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 24, 2018--The “Bydureon 2017 U.S. Promotional Audit Report” report has been added to ResearchAndMarkets.com’s offering. The 5 Key Questions AddressedHow many physicians were reached by Bydureon through reportable promotional activity in 2017 and how does this compare to its peer set in the Type 2 Diabetes - GLP1 market? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity? How does AstraZeneca’s depth of coverage vary within key specialties (e.g., Family Medicine, Internal Medicine, Endocrinology, and General Practice) and how does this compare to its peers and the overall set of rep-accessible physicians? How often are physicians receiving paid meals for Bydureon throughout the year (e.g., monthly, quarterly, annually)? Who were the most frequent meal recipients and top paid speakers for Bydureon in 2017?
Data Sources & MethodologyThe author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than four years of longitudinal data is available - covering payments to more than 975,000 U.S. healthcare professionals. Over 13,600 paid interactions across 7,300 physicians made on behalf of Bydureon were carefully examined to support our analysis.
For more information about this report visit https://www.researchandmarkets.com/research/3lwf67/bydureon?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005423/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/24/2018 06:47 AM/DISC: 09/24/2018 06:47 AM